[1] [9] Retatrutide is an investigational triple receptor agonist that simultaneously targets the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Notably, the risk of major depressive disorder was the highest among female GLP-1 RA users, with a 216% elevated risk (HR: 3.16, 95% CI 2.983.34) compared to non-users, surpassing the risks of anxiety and suicidal ideations or attempts
When used as monotherapy, hypoglycaemia is uncommon
GLP-1 and Health: Beyond Weight Loss in the Ozempic Era
Codeage Liposomal Urolithin A pricing details Unfortunately, Codeage has placed its subscriptions on hold for the time being, so its urolithin A is currently only available as a one-time purchase
This combination improves muscle oxygenation and heart function, as indicated by studies by Mary E